146 related articles for article (PubMed ID: 19526676)
1. [Epilobium parviflorum--in vitro study of biological action].
Hevesi Tóth B; Kéry A
Acta Pharm Hung; 2009; 79(1):3-9. PubMed ID: 19526676
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb.
Hevesi BT; Houghton PJ; Habtemariam S; Kéry A
Phytother Res; 2009 May; 23(5):719-24. PubMed ID: 19107731
[TBL] [Abstract][Full Text] [Related]
3. Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis.
Steenkamp V; Gouws MC; Gulumian M; Elgorashi EE; van Staden J
J Ethnopharmacol; 2006 Jan; 103(1):71-5. PubMed ID: 16122891
[TBL] [Abstract][Full Text] [Related]
4. Polyphenol composition and antioxidant capacity of Epilobium species.
Hevesi Tóth B; Blazics B; Kéry A
J Pharm Biomed Anal; 2009 Jan; 49(1):26-31. PubMed ID: 19013046
[TBL] [Abstract][Full Text] [Related]
5. The effect of chitosan on the stability and morphological parameters of tablets with Epilobium parviflorum Schreb. extract.
Marczyński Z; Bodek KH
Polim Med; 2007; 37(3):3-11. PubMed ID: 18251200
[TBL] [Abstract][Full Text] [Related]
6. [Serenoa repens in benign prostatic hyperplasia].
Log T
Tidsskr Nor Laegeforen; 2008 May; 128(11):1293-4. PubMed ID: 18511974
[TBL] [Abstract][Full Text] [Related]
7. [Phytotherapy for benign prostatic hyperplasia].
Altarac S; Cindro V; Katusin D; Radović N
Lijec Vjesn; 2010; 132(9-10):318-20. PubMed ID: 21261034
[No Abstract] [Full Text] [Related]
8. Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress.
Arredondo MF; Blasina F; Echeverry C; Morquio A; Ferreira M; Abin-Carriquiry JA; Lafon L; Dajas F
J Ethnopharmacol; 2004 Mar; 91(1):13-20. PubMed ID: 15036461
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix.
Chrubasik JE; Roufogalis BD; Wagner H; Chrubasik S
Phytomedicine; 2007 Aug; 14(7-8):568-79. PubMed ID: 17509841
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: can herbs help?
Harv Mens Health Watch; 2004 Nov; 9(4):4-8. PubMed ID: 15556910
[No Abstract] [Full Text] [Related]
11. Characterization of the effect of Epilobium extracts on human cell proliferation.
Vitalone A; McColl J; Thome D; Costa LG; Tita B
Pharmacology; 2003 Oct; 69(2):79-87. PubMed ID: 12928581
[TBL] [Abstract][Full Text] [Related]
12. [Phytotherapy for benign prostatic hyperplasia].
Zengerling F
Urologe A; 2018 Jul; 57(7):846-849. PubMed ID: 29876623
[No Abstract] [Full Text] [Related]
13. Botanical medicines for the urinary tract.
Yarnell E
World J Urol; 2002 Nov; 20(5):285-93. PubMed ID: 12522584
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen and estrogen receptors in benign prostatic hyperplasia].
Wu JQ; Gao X
Zhonghua Nan Ke Xue; 2002; 8(3):212-4. PubMed ID: 12478848
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Effect of Epilobium angustifolium Aqueous Extract on LNCaP Cell Proliferation in In Vitro and In Vivo Models.
Piwowarski JP; Bobrowska-Korczak B; Stanisławska I; Bielecki W; Wrzesien R; Granica S; Krupa K; Kiss AK
Planta Med; 2017 Oct; 83(14-15):1159-1168. PubMed ID: 28454190
[No Abstract] [Full Text] [Related]
16.
Vlase AM; Toiu A; Tomuță I; Vlase L; Muntean D; Casian T; Fizeșan I; Nadăș GC; Novac CȘ; Tămaș M; Crișan G
Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670952
[No Abstract] [Full Text] [Related]
17. Hypoxis hemerocallidea--not merely a cure for benign prostate hyperplasia.
Drewes SE; Elliot E; Khan F; Dhlamini JT; Gcumisa MS
J Ethnopharmacol; 2008 Oct; 119(3):593-8. PubMed ID: 18602776
[TBL] [Abstract][Full Text] [Related]
18. Herb-drug interactions: interactions between ginseng and prescription medications.
Bressler R
Geriatrics; 2005 Aug; 60(8):16-7. PubMed ID: 16092887
[No Abstract] [Full Text] [Related]
19. Herb study is not a practice changer.
Weldy DL
J Fam Pract; 2008 Jun; 57(6):358-9; author reply 359. PubMed ID: 18677803
[No Abstract] [Full Text] [Related]
20. Metabolic profiling, in vitro bioaccessibility and in vivo bioavailability of a commercial bioactive Epilobium angustifolium L. extract.
Dacrema M; Sommella E; Santarcangelo C; Bruno B; Marano MG; Insolia V; Saviano A; Campiglia P; Stornaiuolo M; Daglia M
Biomed Pharmacother; 2020 Nov; 131():110670. PubMed ID: 32896677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
